Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma

Guohui Xu · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
unresectable hepatocellular carcinoma, transarterial chemoembolization, camrelizumab, apatinib, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 893508
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.